ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM) financial statements (2021 and earlier)

Company profile

Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2095761,4013,1621,8931,1341,837
Cash and cash equivalents2095761,4013,1621,8931,1341,837
Receivables 90 189266422391
Prepaid expense    213132 
Other undisclosed current assets31531621247  180
Total current assets:5249821,6133,3992,3721,6882,409
Noncurrent Assets
Property, plant and equipment  8179021,0311,1571,326
Restricted cash and investments55535535535535535
Other noncurrent assets  108112112 112
Other undisclosed noncurrent assets     (1,581) 
Total noncurrent assets:551,4591,5481,6781121,972
Other undisclosed assets     1,692 
TOTAL ASSETS:5299873,0734,9474,0503,4924,381
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8848308373099121,520440
Accounts payable686690315309437346440
Accrued liabilities198139522 4851,174 
Interest and dividends payable    (10)  
Debt  1932522,864246243
Derivative instruments and hedges, liabilities    9061,3161,460
Deferred revenue and credits   152944133
Other undisclosed current liabilities802779 38610 602
Total current liabilities:1,6861,6091,0309614,7213,1252,878
Noncurrent Liabilities
Long-term debt and lease obligation  111579142205
Capital lease obligations  111579142205
Liabilities, other than long-term debt  6763575246
Deferred revenue and credits  6763575246
Total noncurrent liabilities:  7878136194251
Total liabilities:1,6861,6091,1091,0394,8573,3193,129
Stockholders' equity
Stockholders' equity attributable to parent(1,158)(621)1,9643,908(807)1731,252
Common stock128128128128525252
Additional paid in capital30,70130,66630,11230,04517,71317,43217,164
Accumulated deficit(31,987)(31,415)(28,277)(26,265)(18,572)(17,312)(15,964)
Total stockholders' equity:(1,158)(621)1,9643,908(807)1731,252
TOTAL LIABILITIES AND EQUITY:5299873,0734,9474,0503,4924,381

Income statement (P&L) ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Revenues
(Revenue, Net)
 190151993211,499434
Cost of revenue
(Cost of Goods and Services Sold)
      (250)
Gross profit: 190151993211,499184
Operating expenses(549)(2,548)(2,016)(1,936)(1,839)(2,986)(2,664)
Other undisclosed operating income      250
Operating loss:(549)(2,358)(2,001)(1,738)(1,518)(1,487)(2,230)
Nonoperating income (expense)(23)(780)(10)(5,955)258139675
Investment income, nonoperating    410144 
Interest and debt expense     (5)(4)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (4,266)   
Loss from continuing operations before equity method investments, income taxes:(572)(3,139)(2,012)(11,958)(1,261)(1,352)(1,559)
Other undisclosed income from continuing operations before income taxes   4,266 54
Net loss available to common stockholders, diluted:(572)(3,139)(2,012)(7,693)(1,261)(1,348)(1,555)

Comprehensive Income ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Net loss:(572)(3,139)(2,012)(7,693)(1,261)(1,348)(1,555)
Other comprehensive income      1,555
Comprehensive income (loss), net of tax, attributable to parent:(572)(3,139)(2,012)(7,693)(1,261)(1,348)1,555

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: